{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:41:56Z","timestamp":1789792916351,"version":"4.0.1"},"reference-count":138,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2016M3C7A1913844"],"award-info":[{"award-number":["2016M3C7A1913844"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017051","name":"College of Medicine, Seoul National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2014R1A1A1002443"],"award-info":[{"award-number":["2014R1A1A1002443"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2017R1D1A1B03033362"],"award-info":[{"award-number":["NRF-2017R1D1A1B03033362"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002573","name":"Yonsei University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.tranon.2017.12.009","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T03:31:57Z","timestamp":1517628717000},"page":"275-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Multifaceted Roles of Interleukin-6 in Adipocyte\u2013Breast Cancer Cell Interaction"],"prefix":"10.1016","volume":"11","author":[{"given":"Jones","family":"Gyamfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minseob","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Seung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0005","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"7418","key":"10.1016\/j.tranon.2017.12.009_bb0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas N","year":"2012","journal-title":"Nature"},{"issue":"6797","key":"10.1016\/j.tranon.2017.12.009_bb0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.tranon.2017.12.009_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/bcr2912","article-title":"The microenvironment in breast cancer progression: biology and implications for treatment","volume":"13","author":"Place","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"1\u20132","key":"10.1016\/j.tranon.2017.12.009_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10555-012-9415-3","article-title":"Stromal cells in tumor microenvironment and breast cancer","volume":"32","author":"Mao","year":"2013","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/cbt.13.1.18869","article-title":"Tumor microenvironment and breast cancer progression: a complex scenario","volume":"13","author":"Artacho-Cordon","year":"2012","journal-title":"Cancer Biol Ther"},{"issue":"7\u20139","key":"10.1016\/j.tranon.2017.12.009_bb0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1387\/ijdb.113362aa","article-title":"Role of cancer-associated fibroblasts in breast cancer development and prognosis","volume":"55","author":"Aboussekhra","year":"2011","journal-title":"Int J Dev Biol"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2012.05.019","article-title":"Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer","volume":"324","author":"Wang","year":"2012","journal-title":"Cancer Lett"},{"issue":"7\u20139","key":"10.1016\/j.tranon.2017.12.009_bb0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1387\/ijdb.113365jt","article-title":"Adipocyte is a non-trivial, dynamic partner of breast cancer cells","volume":"55","author":"Tan","year":"2011","journal-title":"Int J Dev Biol"},{"issue":"7","key":"10.1016\/j.tranon.2017.12.009_bb0055","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","article-title":"Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion","volume":"71","author":"Dirat","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2014.0026","article-title":"The role of cytokines in breast cancer development and progression","volume":"35","author":"Esquivel-Velazquez","year":"2015","journal-title":"J Interferon Cytokine Res"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cellsig.2013.01.007","article-title":"Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells","volume":"25","author":"Kim","year":"2013","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2013.08.004","article-title":"Interleukin-6: an angiogenic target in solid tumours","volume":"89","author":"Middleton","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0075","first-page":"312","article-title":"Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients","volume":"15","author":"Iwase","year":"2004","journal-title":"Eur Cytokine Netw"},{"issue":"8","key":"10.1016\/j.tranon.2017.12.009_bb0080","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1158\/0008-5472.CAN-15-1443","article-title":"Resistance to anti-VEGF therapy mediated by autocrine IL6\/STAT3 signaling and overcome by IL6 blockade","volume":"76","author":"Eichten","year":"2016","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.tranon.2017.12.009_bb0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1078\/0171-9335-00346","article-title":"The tumor microenvironment: a critical determinant of neoplastic evolution","volume":"82","author":"van Kempen","year":"2003","journal-title":"Eur J Cell Biol"},{"issue":"3\u20134","key":"10.1016\/j.tranon.2017.12.009_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000430499","article-title":"Role of the tumor microenvironment in breast cancer","volume":"82","author":"Soysal","year":"2015","journal-title":"Pathobiology"},{"issue":"Suppl. 5","key":"10.1016\/j.tranon.2017.12.009_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"issue":"17","key":"10.1016\/j.tranon.2017.12.009_bb0100","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1073\/pnas.1401799111","article-title":"Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression","volume":"111","author":"Heinecke","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.seminoncol.2014.03.002","article-title":"Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function","volume":"41","author":"Martinez-Outschoorn","year":"2014","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10911-010-9187-8","article-title":"Diverse and active roles for adipocytes during mammary gland growth and function","volume":"15","author":"Hovey","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"23","key":"10.1016\/j.tranon.2017.12.009_bb0115","doi-asserted-by":"crossref","first-page":"10862","DOI":"10.1158\/0008-5472.CAN-05-1231","article-title":"Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction\/crosstalk at the tumor invasive front","volume":"65","author":"Andarawewa","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13046-017-0494-4","article-title":"Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer","volume":"36","author":"Fletcher","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.tranon.2017.12.009_bb0125","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tranon.2017.12.009_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-physiol-021113-170252","article-title":"A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis","volume":"76","author":"Kajimura","year":"2014","journal-title":"Annu Rev Physiol"},{"issue":"Suppl. 1","key":"10.1016\/j.tranon.2017.12.009_bb0135","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.2337\/diabetes.53.2007.S130","article-title":"The biology of mitochondrial uncoupling proteins","volume":"53","author":"Rousset","year":"2004","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.tranon.2017.12.009_bb0140","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.3361","article-title":"Brown and beige fat: development, function and therapeutic potential","volume":"19","author":"Harms","year":"2013","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.tranon.2017.12.009_bb0145","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1158\/0008-5472.CAN-13-0530","article-title":"Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer","volume":"73","author":"Bochet","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0150","doi-asserted-by":"crossref","first-page":"e0174126","DOI":"10.1371\/journal.pone.0174126","article-title":"Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0160","doi-asserted-by":"crossref","first-page":"e87489","DOI":"10.1172\/jci.insight.87489","article-title":"Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells","volume":"2","author":"Wang","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.tranon.2017.12.009_bb0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.molmed.2017.02.009","article-title":"Adipocyte-tumor cell metabolic crosstalk in breast cancer","volume":"23","author":"Hoy","year":"2017","journal-title":"Trends Mol Med"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0170","doi-asserted-by":"crossref","first-page":"e2593","DOI":"10.1038\/cddis.2017.21","article-title":"Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer","volume":"8","author":"Wen","year":"2017","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10549-015-3550-9","article-title":"Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells","volume":"153","author":"Lee","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1158\/0008-5472.CAN-15-0927","article-title":"Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src\/Sox2\/miR-302b\u2013mediated malignant progression","volume":"76","author":"Picon-Ruiz","year":"2016","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ando.2013.02.007","article-title":"Tumour-surrounding adipocytes are active players in breast cancer progression","volume":"74","author":"Muller","year":"2013","journal-title":"Ann Endocrinol (Paris)"},{"issue":"30","key":"10.1016\/j.tranon.2017.12.009_bb0190","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1038\/onc.2009.130","article-title":"Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells","volume":"28","author":"Walter","year":"2009","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0195","doi-asserted-by":"crossref","first-page":"e0119348","DOI":"10.1371\/journal.pone.0119348","article-title":"Human adipocytes stimulate invasion of breast cancer MCF-7 cells by secreting IGFBP-2","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2010.09.005","article-title":"Molecular mechanisms of leptin and adiponectin in breast cancer","volume":"47","author":"Jarde","year":"2011","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0205","first-page":"31","article-title":"Adiponectin and leptin molecular actions and clinical significance in breast cancer","volume":"8","author":"Nalabolu","year":"2014","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.tranon.2017.12.009_bb0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0083-6729(05)71012-8","article-title":"Leptin: structure, function and biology","volume":"71","author":"Zhang","year":"2005","journal-title":"Vitam Horm"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0215","first-page":"905","article-title":"Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma","volume":"19","author":"Jarde","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.tranon.2017.12.009_bb0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13058-015-0622-z","article-title":"Leptin produced by obese adipose stromal\/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers","volume":"17","author":"Strong","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.tranon.2017.12.009_bb0225","first-page":"340","article-title":"The multifaceted mechanism of leptin signaling within tumor microenvironment in driving breast cancer growth and progression","volume":"4","author":"Ando","year":"2014","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0230","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbrc.2005.06.077","article-title":"Leptin: a proliferative factor for breast cancer? Study on human ductal carcinoma","volume":"334","author":"Caldefie-Chezet","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1006\/bbrc.1999.0843","article-title":"Presence of leptin in breast cell lines and breast tumors","volume":"259","author":"O'Brien","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4331\/wjbc.v6.i2.39","article-title":"Adipocyte activation of cancer stem cell signaling in breast cancer","volume":"6","author":"Wolfson","year":"2015","journal-title":"World J Biol Chem"},{"issue":"6","key":"10.1016\/j.tranon.2017.12.009_bb0245","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1530\/ERC-13-0329","article-title":"Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells","volume":"20","author":"Zheng","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.tranon.2017.12.009_bb0250","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cytogfr.2009.05.007","article-title":"Angiogenesis, adipokines and breast cancer","volume":"20","author":"Vona-Davis","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0260","first-page":"213","article-title":"Role of adiponectin and its receptors in cancer","volume":"9","author":"Obeid","year":"2012","journal-title":"Cancer Biol Med"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0265","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s12032-010-9617-x","article-title":"Adiponectin and breast cancer","volume":"28","author":"Chen","year":"2011","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0270","first-page":"971","article-title":"Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells","volume":"20","author":"Dos Santos","year":"2008","journal-title":"Oncol Rep"},{"issue":"11","key":"10.1016\/j.tranon.2017.12.009_bb0275","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/BF02978210","article-title":"Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell","volume":"28","author":"Kang","year":"2005","journal-title":"Arch Pharm Res"},{"issue":"18","key":"10.1016\/j.tranon.2017.12.009_bb0280","doi-asserted-by":"crossref","first-page":"18341","DOI":"10.1074\/jbc.M501149200","article-title":"Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner","volume":"280","author":"Wang","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0285","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1677\/ERC-09-0043","article-title":"Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies","volume":"16","author":"Jarde","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"15","key":"10.1016\/j.tranon.2017.12.009_bb0290","first-page":"5699","article-title":"Association of serum adiponectin levels with breast cancer risk","volume":"9","author":"Miyoshi","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","article-title":"Adipose tissue as an endocrine organ","volume":"316","author":"Galic","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.1016\/j.tranon.2017.12.009_bb0300","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0305","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-013-2488-z","article-title":"The role of intratumoral and systemic IL-6 in breast cancer","volume":"138","author":"Dethlefsen","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl. 2","key":"10.1016\/j.tranon.2017.12.009_bb0310","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1916","article-title":"Interleukin-6: discovery of a pleiotropic cytokine","volume":"8","author":"Kishimoto","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"Pt 1","key":"10.1016\/j.tranon.2017.12.009_bb0315","first-page":"1","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem J"},{"issue":"Pt 2","key":"10.1016\/j.tranon.2017.12.009_bb0320","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2007.12.020","article-title":"Autocrine IL-6 signaling: a key event in tumorigenesis?","volume":"13","author":"Grivennikov","year":"2008","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0330","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","article-title":"The IL-6\/JAK\/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review)","volume":"44","author":"Wang","year":"2014","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0335","first-page":"305","article-title":"Interleukin-6 and its soluble receptors in human breast cancer","volume":"20","author":"Kuang","year":"1998","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.tranon.2017.12.009_bb0340","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12957-015-0529-2","article-title":"Interleukin-6 and pro inflammatory status in the breast tumor microenvironment","volume":"13","author":"Sanguinetti","year":"2015","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0345","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02967443","article-title":"Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications","volume":"7","author":"Kurebayashi","year":"2000","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0350","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.smim.2014.01.007","article-title":"The IL-6 feed-forward loop: a driver of tumorigenesis","volume":"26","author":"Chang","year":"2014","journal-title":"Semin Immunol"},{"issue":"5","key":"10.1016\/j.tranon.2017.12.009_bb0355","first-page":"2281","article-title":"Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function","volume":"86","author":"Path","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.tranon.2017.12.009_bb0360","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1593\/neo.13706","article-title":"The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis","volume":"15","author":"Chang","year":"2013","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0365","first-page":"e23828","article-title":"Targeting the tumor microenvironment: JAK-STAT3 signaling","volume":"2","author":"Bournazou","year":"2013","journal-title":"JAKSTAT"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0370","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-006-9328-3","article-title":"Significance of interleukin-6 (IL-6) in breast cancer (review)","volume":"102","author":"Knupfer","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.tranon.2017.12.009_bb0375","doi-asserted-by":"crossref","first-page":"535","DOI":"10.5301\/tj.5000357","article-title":"Interleukin-6 as a prognostic marker for breast cancer: a meta-analysis","volume":"101","author":"Lin","year":"2015","journal-title":"Tumori"},{"issue":"7","key":"10.1016\/j.tranon.2017.12.009_bb0380","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2010.02.026","article-title":"Interleukin-6 in bone metastasis and cancer progression","volume":"46","author":"Ara","year":"2010","journal-title":"Eur J Cancer"},{"issue":"13","key":"10.1016\/j.tranon.2017.12.009_bb0385","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1096\/fj.07-8832com","article-title":"Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer","volume":"21","author":"Sasser","year":"2007","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0390","first-page":"1171","article-title":"IL-6\u2013induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures","volume":"40","author":"Xie","year":"2012","journal-title":"Int J Oncol"},{"issue":"6","key":"10.1016\/j.tranon.2017.12.009_bb0395","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tranon.2017.12.009_bb0400","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40169-015-0048-3","article-title":"EMT and tumor metastasis","volume":"4","author":"Heerboth","year":"2015","journal-title":"Clin Transl Med"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0405","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.tranon.2017.12.009_bb0410","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.celrep.2016.02.034","article-title":"Plasticity between epithelial and mesenchymal states unlinks EMT from metastasis-enhancing stem cell capacity","volume":"14","author":"Beerling","year":"2016","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.tranon.2017.12.009_bb0415","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/j.1349-7006.2007.00550.x","article-title":"Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression","volume":"98","author":"Moustakas","year":"2007","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0420","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/bcr2876","article-title":"Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition","volume":"13","author":"Takebe","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"7","key":"10.1016\/j.tranon.2017.12.009_bb0425","first-page":"1696","article-title":"Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis","volume":"53","author":"Oka","year":"1993","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0430","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.yexmp.2012.03.005","article-title":"Mature breast adipocytes promote breast cancer cell motility","volume":"92","author":"Carter","year":"2012","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0435","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/01635589809514719","article-title":"Preadipocytes stimulate breast cancer cell growth","volume":"32","author":"Chamras","year":"1998","journal-title":"Nutr Cancer"},{"issue":"10","key":"10.1016\/j.tranon.2017.12.009_bb0440","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","article-title":"Adipose tissue and adipocytes support tumorigenesis and metastasis","volume":"1831","author":"Nieman","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.tranon.2017.12.009_bb0455","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1158\/1078-0432.CCR-09-2824","article-title":"Cancer stem cells and self-renewal","volume":"16","author":"O'Brien","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tranon.2017.12.009_bb0460","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fphys.2013.00225","article-title":"Breast cancer stem cells","volume":"4","author":"Owens","year":"2013","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0465","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12943-016-0579-2","article-title":"EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression","volume":"16","author":"Pradella","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.tranon.2017.12.009_bb0470","first-page":"2973","article-title":"Links between cancer stem cells and epithelial-mesenchymal transition","volume":"8","author":"Wang","year":"2015","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0475","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.tranon.2017.12.009_bb0480","doi-asserted-by":"crossref","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","article-title":"Generation of breast cancer stem cells through epithelial-mesenchymal transition","volume":"3","author":"Morel","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0485","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr2789","article-title":"Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression","volume":"13","author":"May","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0490","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/bcr1855","article-title":"Brca1 breast tumors contain distinct CD44+\/CD24\u2212 and CD133+ cells with cancer stem cell characteristics","volume":"10","author":"Wright","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0495","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Charafe-Jauffret","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.tranon.2017.12.009_bb0500","doi-asserted-by":"crossref","first-page":"a003160","DOI":"10.1101\/cshperspect.a003160","article-title":"Stem cells in the human breast","volume":"2","author":"Petersen","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0505","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2016.02.048","article-title":"Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: a snapshot of IL-6 mediated involvement","volume":"375","author":"Bharti","year":"2016","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0510","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrclinonc.2010.196","article-title":"Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways","volume":"8","author":"Takebe","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"23","key":"10.1016\/j.tranon.2017.12.009_bb0515","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","article-title":"Biology of cachexia","volume":"89","author":"Tisdale","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0520","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","article-title":"Cancer cachexia: impact, mechanisms and emerging treatments","volume":"4","author":"Vaughan","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2017.12.009_bb0525","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0530","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.tranon.2017.12.009_bb0535","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2014.07.005","article-title":"The browning of white adipose tissue: some burning issues","volume":"20","author":"Nedergaard","year":"2014","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.tranon.2017.12.009_bb0540","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/BSR20130046","article-title":"Turning WAT into BAT: a review on regulators controlling the browning of white adipocytes","volume":"33","author":"Lo","year":"2013","journal-title":"Biosci Rep"},{"issue":"8","key":"10.1016\/j.tranon.2017.12.009_bb0545","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.tem.2016.06.006","article-title":"White adipose tissue browning: a double-edged sword","volume":"27","author":"Abdullahi","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0550","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JES.0b013e3181f44f11","article-title":"Interleukin 6 as a key regulator of muscle mass during cachexia","volume":"38","author":"Carson","year":"2010","journal-title":"Exerc Sport Sci Rev"},{"issue":"5","key":"10.1016\/j.tranon.2017.12.009_bb0555","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.tranon.2017.12.009_bb0560","first-page":"255","article-title":"Cytokines in cancer drug resistance: cues to new therapeutic strategies","volume":"1865","author":"Jones","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.tranon.2017.12.009_bb0565","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"issue":"18","key":"10.1016\/j.tranon.2017.12.009_bb0570","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tranon.2017.12.009_bb0575","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1748-717X-8-159","article-title":"The role of IL-6 in the radiation response of prostate cancer","volume":"8","author":"Wu","year":"2013","journal-title":"Radiat Oncol"},{"issue":"11","key":"10.1016\/j.tranon.2017.12.009_bb0580","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.bjc.6600956","article-title":"Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients","volume":"88","author":"Bachelot","year":"2003","journal-title":"Br J Cancer"},{"issue":"24","key":"10.1016\/j.tranon.2017.12.009_bb0585","first-page":"8851","article-title":"Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells","volume":"61","author":"Conze","year":"2001","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.tranon.2017.12.009_bb0590","first-page":"2899","article-title":"Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells","volume":"31","author":"Jiang","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.tranon.2017.12.009_bb0595","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13058-015-0569-0","article-title":"Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity","volume":"17","author":"Duong","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0600","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbrc.2011.06.101","article-title":"Cancer-associated adipocytes promotes breast tumor radioresistance","volume":"411","author":"Bochet","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"10.1016\/j.tranon.2017.12.009_bb0605","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-15-1227","article-title":"Interleukin-6 stimulates defective angiogenesis","volume":"75","author":"Gopinathan","year":"2015","journal-title":"Cancer Res"},{"issue":"36","key":"10.1016\/j.tranon.2017.12.009_bb0610","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1038\/sj.onc.1208719","article-title":"Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways","volume":"24","author":"Xu","year":"2005","journal-title":"Oncogene"},{"issue":"6801","key":"10.1016\/j.tranon.2017.12.009_bb0615","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.tranon.2017.12.009_bb0620","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.tranon.2017.12.009_bb0625","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.tranon.2017.12.009_bb0630","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1172\/JCI32533","article-title":"IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland","volume":"117","author":"Sansone","year":"2007","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.tranon.2017.12.009_bb0635","first-page":"4653","article-title":"Targeted anti\u2013interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence","volume":"9","author":"Trikha","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"5\u20136","key":"10.1016\/j.tranon.2017.12.009_bb0640","doi-asserted-by":"crossref","first-page":"247","DOI":"10.20452\/pamw.144","article-title":"Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease","volume":"117","author":"Lukaszewicz","year":"2007","journal-title":"Pol Arch Med Wewn"},{"issue":"9","key":"10.1016\/j.tranon.2017.12.009_bb0645","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.tranon.2017.12.009_bb0650","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","article-title":"Interleukin-6 as a therapeutic target","volume":"21","author":"Rossi","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.tranon.2017.12.009_bb0655","first-page":"639","article-title":"CNTO-328 (Centocor)","volume":"6","author":"Li","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0660","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ijc.20270","article-title":"CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice","volume":"111","author":"Zaki","year":"2004","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0665","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trsl.2015.08.013","article-title":"Therapeutics targeting innate immune\/inflammatory responses through the interleukin-6\/JAK\/STAT signal transduction pathway in patients with cancer","volume":"167","author":"Roxburgh","year":"2016","journal-title":"Transl Res"},{"issue":"5","key":"10.1016\/j.tranon.2017.12.009_bb0670","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/mc.22325","article-title":"Antitumor effects of interleukin-6 (IL-6)\/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary","volume":"55","author":"Yanaihara","year":"2016","journal-title":"Mol Carcinog"},{"issue":"8","key":"10.1016\/j.tranon.2017.12.009_bb0675","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.bjc.6605872","article-title":"A phase I\/II study of siltuximab (CNTO 328), an anti\u2013interleukin-6 monoclonal antibody, in metastatic renal cell cancer","volume":"103","author":"Rossi","year":"2010","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.tranon.2017.12.009_bb0680","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1158\/1078-0432.CCR-09-2581","article-title":"Pharmacokinetic and pharmacodynamic modeling of an anti\u2013interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma","volume":"16","author":"Puchalski","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0685","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejca.2011.10.014","article-title":"Randomised phase II study of siltuximab (CNTO 328), an anti\u2013IL-6 monoclonal antibody, in combination with mitoxantrone\/prednisone versus mitoxantrone\/prednisone alone in metastatic castration-resistant prostate cancer","volume":"48","author":"Fizazi","year":"2012","journal-title":"Eur J Cancer"},{"issue":"13","key":"10.1016\/j.tranon.2017.12.009_bb0690","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/pros.21362","article-title":"The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study","volume":"71","author":"Karkera","year":"2011","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.tranon.2017.12.009_bb0695","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/07853890.2013.771986","article-title":"Tocilizumab: a novel humanized anti\u2013interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases","volume":"45","author":"Alten","year":"2013","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.tranon.2017.12.009_bb0700","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/intimm\/dxu081","article-title":"Therapeutic uses of anti-interleukin-6 receptor antibody","volume":"27","author":"Kang","year":"2015","journal-title":"Int Immunol"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523317304060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523317304060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:34:29Z","timestamp":1761834869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523317304060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1936523317304060"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2017.12.009","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifaceted Roles of Interleukin-6 in Adipocyte\u2013Breast Cancer Cell Interaction","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}